Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 5th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK | GSK PLC | $96.86B | $48.02 | N/A | N/A | N/A | N/A | -5.16% | -17.69% | 42.74% | 11.25% | |||
| MRK | MERCK & CO INC | $259.69B | $104.63 | $104.20 | -0.41% | Hold | 5 | 4.12% | 11.27% | 51.83% | 20.74% | |||
| BMY | BRISTOL MYERS SQUIBB CO | $100.26B | $49.25 | $39.50 | -19.80% | Sell | 2 | -3.55% | 25.52% | 61.29% | 11.74% | |||
| GRFS | GRIFOLS SA | $6.04B | $8.78 | $10.30 | 17.31% | Hold | 1 | 2.33% | 69.33% | 16.03% | 4.41% | |||
| LLY | ELI LILLY & CO | $1.04T | $1,104.34 | $1.07k | -2.86% | Strong Buy | 14 | 13.44% | 22.53% | 180.92% | 37.45% | |||
| GILD | GILEAD SCIENCES INC | $158.20B | $127.51 | $133.82 | 4.95% | Strong Buy | 11 | 3.37% | 13.25% | 59.22% | 21.79% | |||
| AMGN | AMGEN INC | $185.54B | $344.57 | $317.75 | -7.78% | Hold | 8 | 1.83% | 20.50% | 131.71% | 14.05% | |||
| ABBV | ABBVIE INC | $402.36B | $227.66 | $252.08 | 10.73% | Strong Buy | 13 | 6.88% | 131.71% | -1,197.32% | 23.62% | |||
| AMRN | AMARIN CORP PLC | $335.59M | $16.14 | $12.00 | -25.65% | Strong Sell | 1 | -4.16% | N/A | 101.68% | 70.72% | |||
| JNJ | JOHNSON & JOHNSON | $500.07B | $207.56 | $199.71 | -3.78% | Buy | 14 | 4.31% | 6.04% | 40.56% | 16.68% | |||
| AZN | ASTRAZENECA PLC | $289.29B | $93.32 | N/A | N/A | N/A | N/A | 4.94% | 57.36% | 44.53% | 17.85% | |||
| SNY | SANOFI | $126.39B | $50.03 | $58.00 | 15.93% | Strong Buy | 1 | 0.36% | 28.31% | 15.44% | 8.65% | |||
| NVS | NOVARTIS AG | $251.23B | $130.44 | $118.00 | -9.54% | Strong Sell | 1 | 2.14% | 11.37% | 48.53% | 20.05% | |||
| OGN | ORGANON & CO | $2.01B | $7.74 | $10.50 | 35.66% | Sell | 2 | 0.80% | 29.90% | 124.34% | 8.31% | |||
| PFE | PFIZER INC | $146.18B | $25.71 | $30.75 | 19.60% | Buy | 4 | -0.54% | 22.60% | 16.71% | 7.43% | |||
| BIIB | BIOGEN INC | $26.69B | $181.94 | $168.33 | -7.48% | Buy | 9 | -2.44% | 13.75% | 13.49% | 8.41% | |||
| SCLX | SCILEX HOLDING CO | $154.29M | $20.34 | N/A | N/A | N/A | N/A | 135.01% | N/A | -40.94% | 26.67% | |||
| MIRA | MIRA PHARMACEUTICALS INC | $61.56M | $1.47 | N/A | N/A | N/A | N/A | N/A | N/A | -53.75% | -53.16% | |||
| MDCX | MEDICUS PHARMA LTD | $45.16M | $2.05 | $27.00 | 1,217.07% | Strong Buy | 1 | N/A | N/A | N/A | -33.78% | |||
| NSRX | NASUS PHARMA LTD | N/A | $7.00 | $22.00 | 214.29% | Strong Buy | 1 | N/A | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.